Clinical Trials Logo

Filter by:
NCT ID: NCT05226949 Completed - Neonatal Sepsis Clinical Trials

Host RNA Expression Profiles and Protein Biomarkers in Neonatal Herpes Simplex Virus Infection

Start date: January 1, 2022
Phase:
Study type: Observational

This study seeks to identify and test host RNA expression profiles in context to protein biomarkers in dried blood spot samples as novel diagnostic markers of neonatal herpes simplex virus infection and to improve the understanding of the pathogenesis of the disease.

NCT ID: NCT05225480 Completed - Knee Osteoarthritis Clinical Trials

Reinforcement of Placebo Response in Knee Osteoarthritis: A Randomised Trial

Start date: April 21, 2022
Phase: N/A
Study type: Interventional

Saline intra-articular injections used as placebo treatments have been shown to provide pain relief in knee osteoarthritis (OA) It has further been shown that beneficial effects can be induced merely by having a conversation with a health professional. The aim of this study is to determine whether an individual conversation based on the individual's illness perception related to knee OA affects the response to an intra-articular treatment with saline in individuals with knee OA.

NCT ID: NCT05223855 Completed - Stress Clinical Trials

Effect of Aquatic Physiotherapy for People With Stress

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

Brief summary: Effect of aquatic physiotherapy for people with stress; a randomized controlled trial (RCT) The purpose of the project is to investigate the effect of aquatic physiotherapy treatment in 34-36 degrees warm water. The study is a randomized controlled trial, and participants are recruited from GPs in Lyngby-Taarbæk as well as Gentofte Kommune. The participants are randomized using numbered, opaque and sealed envelopes. Method: The intervention Aquatic physiotherapy 1: 1 treatment in 34-36 degrees centigrade warm water. The participant is placed supine in the water, supported by the physiotherapist as well as aqua noodles. The physiotherapist supports and moves the participant in the water and adapts to the participant's reaction. Intervention Group: The intervention group is treated twice a week. Duration of each treatment is 30 minutes. Period of treatment is 8 weeks. Control Group: The control group receives usual care through their GP for 8 weeks. Then they are offered participation in a de-stress class in 34-36 degrees centigrade warm water, twice a week. Duration of each treatment is 30 minutes. Period of treatment is 8 weeks. EFFECT MEASURES: 1. Primary effect measures: Change of stress level from baseline using validated questionnaire Cohen's Perceived Stress Scale (PSS). 2. Secondary effect measures: Change of sleep disorders from baseline using validated questionnaire Pittsburgh Sleep Quality Index (PSQI). Measurements to be taken before and after 8-weeks intervention

NCT ID: NCT05223504 Completed - Clinical trials for Clinical Deterioration

WARD-Home - Continuous Monitoring of Vital Parameters After Discharge

Start date: August 1, 2021
Phase:
Study type: Observational [Patient Registry]

The current pilot study aims to investigate the feasibility of wireless, continuous monitoring of patients in the days around discharge after an acute medical hospitalization, as well as occurrence of deviating vital signs in this patient group.

NCT ID: NCT05218525 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Testing a Prediction Algorithm Into a Running Telehealth System for Patients With COPD

Start date: October 1, 2021
Phase: N/A
Study type: Interventional

This trial will test a COPD prediction algorithm into a telehealth system from the previous Danish large-scale trial, TeleCare North (NCT01984840). The COPD prediction algorithm aims to support clinical decisions by predicting exacerbations in patients with COPD based on selected physiological parameters (blood pressure, oxygen saturation, and pulse). A prospective, parallel two-armed randomized controlled trial with approximately 200 COPD participants will be conducted.

NCT ID: NCT05215938 Completed - Image, Body Clinical Trials

Evaluation of Intra Organ Sodium Levels by Magnetic Resonance Imaging

Start date: July 7, 2021
Phase:
Study type: Observational

The investigators aim to implement an innovative imaging tool for detection of sodium level changes in-vivo with a clinical magnetic resonance (MR) scanner system. Conventionally, MR imaging (MRI) is performed with the use of proton imaging. Nevertheless, detection of other nuclei such as sodium (23Na) are possible with dedicated radio frequency sequences and radio frequency antennas tuned to the lower radio frequency of sodium. Non-invasive detection of sodium level changes has great potential as a precursor of organ deficiency and possible organ failure. This project seeks to determine a robust method for detection and characterization of sodium levels with MRI. The sodium levels of the kidneys are known to change throughout the day. Therefore, an evaluation of the kidney circadian sodium level variation is performed. In the proposed project, the investigators will scan two groups divided into two separate studies: Healthy controls for optimization of imaging (n = 5, scanned twice) Healthy controls for comparison of circadian variation (n = 10, scanned triple on one day) Sodium MRI could greatly improve the understanding and diagnostic capabilities of several medical conditions. If successful, the proposed project will serve as the groundwork for future clinical studies.

NCT ID: NCT05215678 Completed - Knee Osteoarthritis Clinical Trials

Characteristics of Patients Declining INKA Trial Participation

n-INKA
Start date: February 1, 2022
Phase:
Study type: Observational

The objective of this study is to compare baseline characteristics of overweight knee OA patients accepting vs. declining enrolment in the INKA trial (NCT05172843) to explore if enrolled patients differ systematically from the declining participants with respect to both measured as well as unmeasured baseline characteristics.

NCT ID: NCT05215509 Completed - Clinical trials for Rheumatoid Arthritis

Exercise-induced Cardiac Adaptions in Rheumatoid Arthritis Patients During IL-6 vs. TNF Antibody Therapy

RABEX
Start date: January 1, 2021
Phase: N/A
Study type: Interventional

The present study will investigative the physiological effects of the cytokines interleukin-6 (IL-6) and tumor necrosis factor (TNF) on the adaptive changes to exercise in patients with rheumatoid arthritis. The investigators hypothesize that blockage of IL-6 receptors will decrease the cardiac and metabolic adaptations to exercise training compared to the inhibition of TNF. 80 patients will be included in a 12-week investigator blinded randomised exercise training intervention study.

NCT ID: NCT05209321 Completed - Lymphoma Clinical Trials

Predictors of Malnutrition in Patients With Haematological Cancer

Start date: April 1, 2021
Phase:
Study type: Observational [Patient Registry]

The primary purpose of this study is to conduct an exploratory study of which predictors are most significant for LBM loss in patients with lymphoma. Patients are measured by weight and bio impedance and furthermore, their physical activity, nutritional status, diet and quality of life during the course are estimated. This is done in order to determine any changes in the aforementioned factors during the course of the cancer treatment that may have a bearing on the loss of LBM.

NCT ID: NCT05209178 Completed - COVID-19 Pandemic Clinical Trials

Diagnostic Accuracy of Self-sampling Versus Healthcare Sampling for Coronavirus-Disease-2019 Detection.

COVID-19
Start date: February 4, 2022
Phase: N/A
Study type: Interventional

The current Coronavirus Disease 2019 (COVID-19) pandemic continues to be a worldwide health emergency. To contain the spread of disease, high demands on testing availability and capacity are observed. Although polymerase chain reaction (PRC) is the golden standard method in detecting infection with COVID-19, the procedure is time consuming and requires healthcare personnel and laboratories. Rapid antigen tests, however, have several potential benefits including greater scalability and results are provided much quicker. So far, sampling for rapid antigen tests is predominantly performed by health care personnel. Though, the testing and analyzing procedure of an antigen test seems manageable by laymen but the validity of a self-performed rapid antigen test is sparsely examined. Thus, the investigators wish to conduct a study evaluating the diagnostic accuracy of self-performed rapid antigen test for detecting COVID-19 infection by comparing self-performed and healthcare-performed rapid antigen tests on the same individual while using a PCR tests as a control.